Real World Effectiveness and Safety of Super Bioavailable Itraconazole for Glabrous Dermatophytosis in India: A Multi Centre Retrospective Analysis

Dear Editor, In recent years, India has seen a significant rise in the prescription of itraconazole for the management of dermatophytosis [1]. However, its pharmacokinetic variability has often led to inconsistent clinical outcomes. To address these challenges, a newer formulation-Super-Bioavailable Itraconazole (SB-ITZ) has been commercialized in India [2]. Although SB-ITZ has supportive pharmacokinetic and clinical data, large scale real world evidence remains limited. We therefore undertook a retrospective, record based evaluation of SB ITZ in Indian patients with dermatophytosis.